2018-2023 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report (Status and Outlook)
- LP 2623316
- 153 Pages
- June 2018
- Medical Devices
Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs).
The CellSearch test is the only FDA-approved test for CTC assessment. For the moment, the products are not comprehensive, and technologies are not stable.
Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively.
Over the next five years, LPI(LP Information) projects that Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) will register a 22.5% CAGR in terms of revenue, reach US$ 21700 million by 2023, from US$ 6420 million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
CellSearch
Others
Segmentation by application:
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by identifying its various subsegments.
Focuses on the key global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2013-2023
2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region
2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Type
2.2.1 CellSearch
2.2.2 Others
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
2.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
2.3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type (2013-2018)
2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Application
2.4.1 Breast Cancer Diagnosis and Treatment
2.4.2 Prostate Cancer Diagnosis and Treatment
2.4.3 Colorectal Cancer Diagnosis and Treatment
2.4.4 Lung Cancer Diagnosis and Treatment
2.4.5 Other Cancers Diagnosis and Treatment
2.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
2.5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
2.5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Application (2013-2018)
3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Players
3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Players (2016-2018)
3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players (2016-2018)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions
4.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions
4.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
4.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
4.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
4.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
5 Americas
5.1 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries
5.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
5.3 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries
6.2 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
6.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
7.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
8.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
8.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2018-2023)
10.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions
10.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Type
10.8 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Application
11 Key Players Analysis
11.1 Janssen
11.1.1 Company Details
11.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Janssen News
11.2 Qiagen
11.2.1 Company Details
11.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Qiagen News
11.3 Advanced Cell Diagnostics
11.3.1 Company Details
11.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Advanced Cell Diagnostics News
11.4 ApoCell
11.4.1 Company Details
11.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 ApoCell News
11.5 Biofluidica
11.5.1 Company Details
11.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Biofluidica News
11.6 Clearbridge Biomedics
11.6.1 Company Details
11.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Clearbridge Biomedics News
11.7 CytoTrack
11.7.1 Company Details
11.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 CytoTrack News
11.8 Celsee
11.8.1 Company Details
11.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Celsee News
11.9 Fluxion
11.9.1 Company Details
11.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Fluxion News
11.10 Gilupi
11.10.1 Company Details
11.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Gilupi News
11.11 Cynvenio
11.12 On-chip
11.13 YZY Bio
11.14 BioView
11.15 Fluidigm
11.16 Ikonisys
11.17 AdnaGen
11.18 IVDiagnostics
11.19 Miltenyi Biotec
11.20 ScreenCell
11.21 Silicon Biosystems
12 Research Findings and Conclusion
Table Product Specifications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report Years Considered
Figure Market Research Methodology
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate 2013-2023 ($ Millions)
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of CellSearch
Table Major Players of Others
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
Figure Global CellSearch Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumed in Breast Cancer Diagnosis and Treatment
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Breast Cancer Diagnosis and Treatment (2013-2018) ($ Millions)
Figure Global Breast Cancer Diagnosis and Treatment YoY Growth ($ Millions)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumed in Prostate Cancer Diagnosis and Treatment
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Prostate Cancer Diagnosis and Treatment (2013-2018) ($ Millions)
Figure Global Prostate Cancer Diagnosis and Treatment YoY Growth ($ Millions)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumed in Colorectal Cancer Diagnosis and Treatment
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Colorectal Cancer Diagnosis and Treatment (2013-2018) ($ Millions)
Figure Global Colorectal Cancer Diagnosis and Treatment YoY Growth ($ Millions)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumed in Lung Cancer Diagnosis and Treatment
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Lung Cancer Diagnosis and Treatment (2013-2018) ($ Millions)
Figure Global Lung Cancer Diagnosis and Treatment YoY Growth ($ Millions)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumed in Other Cancers Diagnosis and Treatment
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Other Cancers Diagnosis and Treatment (2013-2018) ($ Millions)
Figure Global Other Cancers Diagnosis and Treatment YoY Growth ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2013-2018) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size in Breast Cancer Diagnosis and Treatment Growth Rate
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size in Prostate Cancer Diagnosis and Treatment Growth Rate
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size in Colorectal Cancer Diagnosis and Treatment Growth Rate
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size in Lung Cancer Diagnosis and Treatment Growth Rate
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size in Other Cancers Diagnosis and Treatment Growth Rate
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2016-2018) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players (2016-2018)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players in 2017
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions 2013-2018 ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions 2013-2018
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions 2013-2018
Figure Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2013-2018 ($ Millions)
Figure APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2013-2018 ($ Millions)
Figure Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2013-2018 ($ Millions)
Table Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2013-2018) ($ Millions)
Table Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2013-2018)
Figure Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2017
Table Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2013-2018) ($ Millions)
Table Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
Figure Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2017
Table Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2013-2018) ($ Millions)
Table Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
Figure Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2017
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Table APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2013-2018) ($ Millions)
Table APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2013-2018)
Figure APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2017
Table APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2013-2018) ($ Millions)
Table APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
Figure APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2017
Table APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2013-2018) ($ Millions)
Table APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
Figure APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2017
Figure China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2013-2018) ($ Millions)
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2013-2018)
Figure Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2017
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2013-2018) ($ Millions)
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
Figure Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2017
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2013-2018) ($ Millions)
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
Figure Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2017
Figure Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2017
Table Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2017
Table Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2017
Figure Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2013-2018 ($ Millions)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) arket Size Forecast (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Regions
Figure Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Figure GCC Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2018-2023 ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Type (2018-2023)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Application (2018-2023)
Table Janssen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Qiagen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Advanced Cell Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table ApoCell Basic Information, Head Office, Major Market Areas and Its Competitors
Table ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Biofluidica Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Clearbridge Biomedics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table CytoTrack Basic Information, Head Office, Major Market Areas and Its Competitors
Table CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Celsee Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Fluxion Basic Information, Head Office, Major Market Areas and Its Competitors
Table Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Gilupi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2016-2018)
Figure Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2016-2018)
Table Cynvenio Basic Information, Head Office, Major Market Areas and Its Competitors
Table On-chip Basic Information, Head Office, Major Market Areas and Its Competitors
Table YZY Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioView Basic Information, Head Office, Major Market Areas and Its Competitors
Table Fluidigm Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ikonisys Basic Information, Head Office, Major Market Areas and Its Competitors
Table AdnaGen Basic Information, Head Office, Major Market Areas and Its Competitors
Table IVDiagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Miltenyi Biotec Basic Information, Head Office, Major Market Areas and Its Competitors
Table ScreenCell Basic Information, Head Office, Major Market Areas and Its Competitors
Table Silicon Biosystems Basic Information, Head Office, Major Market Areas and Its Competitors
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
